Hirano, Seiichi
Abudayyeh, Omar O.
Gootenberg, Jonathan S.
Horii, Takuro
Ishitani, Ryuichiro
Hatada, Izuho
Zhang, Feng
Nishimasu, Hiroshi
Nureki, Osamu http://orcid.org/0000-0003-1813-7008
Article History
Received: 7 October 2018
Accepted: 29 March 2019
First Online: 29 April 2019
Competing interests
: J.S.G., O.O.A. and F.Z. are co-founders of Sherlock Biosciences. O.O.A. and J.S.G. are advisors for Beam Therapeutics. J.S.G. is a campus advisor of Benchling, Inc. F.Z. is a co-founder and advisor of Editas Medicine, Arbor Biotechnologies, Beam Therapeutics, and Pairwise Plants. H.N. is an advisor of EdiGENE. O.N. is a co-founder and advisor of EdiGENE. The remaining authors declare no competing interests.